Sakar Healthcare

{
  "main_header": {
    "sid": 1002668,
    "name": "Sakar Healthcare",
    "stock_name": "Sakar Healthcare",
    "full_name": "Sakar Healthcare Ltd",
    "name_url": "stocks-analysis/sakar-healthcare",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "518.40",
    "chg": -18.05,
    "chgp": "-3.36%",
    "dir": -1,
    "prev_price": "536.45",
    "mcapval": "1,191.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "SAKAR",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE732S01012",
    "curr_date": "Mar 27",
    "curr_time": "",
    "bse_nse_vol": 42956,
    "exc_status": "Active",
    "traded_date": "Mar 27, 2026",
    "traded_date_str": "2026 03 27",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/sakar-healthcare-1002668-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Sakar Healthcare Ltd is Rated Buy",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sakar-healthcare-ltd-is-rated-buy-3902935",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SakarHealthcare_mojoScore_3902935.png",
        "date": "2026-03-20 10:10:03",
        "description": "Sakar Healthcare Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 05 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 March 2026, providing investors with an up-to-date view of its performance and prospects."
      },
      {
        "title": "Sakar Healthcare Ltd is Rated Buy",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sakar-healthcare-ltd-is-rated-buy-3879317",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SakarHealthcare_mojoScore_3879317.png",
        "date": "2026-03-09 10:10:02",
        "description": "Sakar Healthcare Ltd is rated Buy by MarketsMOJO, with this rating last updated on 05 February 2026. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 09 March 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Sakar Healthcare Ltd is Rated Buy",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sakar-healthcare-ltd-is-rated-buy-3879254",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SakarHealthcare_mojoScore_3879254.png",
        "date": "2026-03-08 10:10:03",
        "description": "Sakar Healthcare Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 05 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 March 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Sakar Healthcare Ltd is Rated Buy",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sakar-healthcare-ltd-is-rated-buy-3855325",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SakarHealthcare_mojoScore_3855325.png",
        "date": "2026-02-25 10:10:04",
        "description": "Sakar Healthcare Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 05 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 February 2026, providing investors with the most up-to-date insight into the company’s performance and outlook."
      },
      {
        "title": "Sakar Healthcare Ltd is Rated Buy by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sakar-healthcare-ltd-is-rated-buy-by-marketsmojo-3839215",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SakarHealthcare_mojoScore_3839215.png",
        "date": "2026-02-14 10:10:05",
        "description": "Sakar Healthcare Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 05 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 14 February 2026, providing investors with the most up-to-date insight into the company’s performance and outlook."
      },
      {
        "title": "Sakar Healthcare Ltd Emerges as a Multibagger with Over 100% Returns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sakar-healthcare-ltd-emerges-as-a-multibagger-with-over-100-returns-3835258",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SakarHealthcare_multibagger_3835258.png",
        "date": "2026-02-12 13:35:08",
        "description": "Sakar Healthcare Ltd has emerged as a standout performer in the Pharmaceuticals & Biotechnology sector, delivering multibagger returns of over 100% in the past year. Outperforming the Sensex by a wide margin, the stock’s remarkable growth is underpinned by robust financials, strong institutional interest, and consistent operational improvements, making it a compelling buy for investors seeking sustained momentum in a competitive industry."
      },
      {
        "title": "Sakar Healthcare Surges 11.81%: 5 Key Developments Driving the Rally",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sakar-healthcare-surges-1181-5-key-developments-driving-the-rally-3826100",
        "imagepath": "",
        "date": "2026-02-07 13:02:02",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>2 Feb:</strong> Stock opens at ₹383.05, down 2.06% amid broader market weakness</p>\n                    <p><strong>3 Feb:</strong> Sharp rebound with 5.39% gain to ₹403.70, supported by technical momentum</p>\n                    <p><strong>4 Feb:</strong> Bullish momentum shift confirmed by technical indicators; stock closes at ₹409.80 (+1.51%)</p>\n                    <p><strong>5 Feb:</strong> Outstanding quarterly results propel stock 6.09% higher to ₹434.75</p>\n                    <p><strong>6 Feb:</strong> Continued bullish momentum lifts stock to ₹437.30 (+0.59%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><di..."
      },
      {
        "title": "Sakar Healthcare Ltd Technical Momentum Shifts Signal Bullish Outlook",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sakar-healthcare-ltd-technical-momentum-shifts-signal-bullish-outlook-3823685",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SakarHealthcare_technicaldot_3823685.png",
        "date": "2026-02-06 08:03:09",
        "description": "Sakar Healthcare Ltd has demonstrated a significant shift in price momentum, moving from a mildly bullish to a bullish technical trend, supported by a confluence of positive signals across key indicators such as MACD, RSI, moving averages, and Bollinger Bands. This technical upgrade accompanies a notable 6.09% gain in the stock price on 6 Feb 2026, reflecting renewed investor confidence in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Are Sakar Healthcare Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-sakar-healthcare-ltd-latest-results-good-or-bad-3822931",
        "imagepath": "",
        "date": "2026-02-05 19:29:44",
        "description": "Sakar Healthcare Ltd's latest financial results for the quarter ending December 2025 reflect a significant operational performance, characterized by robust growth in both revenue and net profit. The company reported a year-on-year revenue increase of 62.00%, reaching ₹70.34 crores, which notably surpasses its five-year sales growth rate of 16.59%. This acceleration indicates effective market penetration and possibly favorable industry dynamics.\n\nThe net profit for the same period surged by 126.27% year-on-year to ₹10.25 crores, showcasing strong profitability driven by improved operational efficiency and cost management. The operating margin, excluding other income, improved to 26.43%, marking a substantial enhancement from the previous quarter. This margin expansion is attributed to better operating leverage as revenue scaled, alongside controlled employee costs and reduced interest expenses.\n\nDespite thes..."
      }
    ],
    "total": 390,
    "sid": "1002668",
    "stock_news_url": "https://www.marketsmojo.com/news/sakar-healthcare-1002668"
  },
  "announcements": [
    {
      "details": "Sakar Healthcare Limitedealthcare Limited for the quarter ended 30-Sep-2019 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.",
      "source": "NSE",
      "caption": "Sakar Healthcare Limited - Reply to Clarification- Financial results",
      "datetime": "09-Dec-2019"
    },
    {
      "details": "Sakar Healthcare Limitede Limited for the quarter ended 30-Sep-2019 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.",
      "source": "NSE",
      "caption": "Sakar Healthcare Limited - Clarification - Financial Results",
      "datetime": "03-Dec-2019"
    },
    {
      "details": "Sakar Healthcare Limited has informed the Exchange regarding Board meeting held on November 14, 2019.",
      "source": "NSE",
      "caption": "Sakar Healthcare Limited - Outcome of Board Meeting",
      "datetime": "14-Nov-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Sakar Healthcare Ltd is Rated Buy

2026-03-20 10:10:03

Sakar Healthcare Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 05 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 March 2026, providing investors with an up-to-date view of its performance and prospects.

Read full news article

Sakar Healthcare Ltd is Rated Buy

2026-03-09 10:10:02

Sakar Healthcare Ltd is rated Buy by MarketsMOJO, with this rating last updated on 05 February 2026. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 09 March 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Sakar Healthcare Ltd is Rated Buy

2026-03-08 10:10:03

Sakar Healthcare Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 05 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 March 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Sakar Healthcare Ltd is Rated Buy

2026-02-25 10:10:04

Sakar Healthcare Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 05 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 February 2026, providing investors with the most up-to-date insight into the company’s performance and outlook.

Read full news article

Sakar Healthcare Ltd is Rated Buy by MarketsMOJO

2026-02-14 10:10:05

Sakar Healthcare Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 05 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 14 February 2026, providing investors with the most up-to-date insight into the company’s performance and outlook.

Read full news article

Sakar Healthcare Ltd Emerges as a Multibagger with Over 100% Returns

2026-02-12 13:35:08

Sakar Healthcare Ltd has emerged as a standout performer in the Pharmaceuticals & Biotechnology sector, delivering multibagger returns of over 100% in the past year. Outperforming the Sensex by a wide margin, the stock’s remarkable growth is underpinned by robust financials, strong institutional interest, and consistent operational improvements, making it a compelling buy for investors seeking sustained momentum in a competitive industry.

Read full news article

Sakar Healthcare Surges 11.81%: 5 Key Developments Driving the Rally

2026-02-07 13:02:02

Key Events This Week

2 Feb: Stock opens at ₹383.05, down 2.06% amid broader market weakness

3 Feb: Sharp rebound with 5.39% gain to ₹403.70, supported by technical momentum

4 Feb: Bullish momentum shift confirmed by technical indicators; stock closes at ₹409.80 (+1.51%)

5 Feb: Outstanding quarterly results propel stock 6.09% higher to ₹434.75

6 Feb: Continued bullish momentum lifts stock to ₹437.30 (+0.59%)

Read full news article

Sakar Healthcare Ltd Technical Momentum Shifts Signal Bullish Outlook

2026-02-06 08:03:09

Sakar Healthcare Ltd has demonstrated a significant shift in price momentum, moving from a mildly bullish to a bullish technical trend, supported by a confluence of positive signals across key indicators such as MACD, RSI, moving averages, and Bollinger Bands. This technical upgrade accompanies a notable 6.09% gain in the stock price on 6 Feb 2026, reflecting renewed investor confidence in the Pharmaceuticals & Biotechnology sector.

Read full news article

Are Sakar Healthcare Ltd latest results good or bad?

2026-02-05 19:29:44

Sakar Healthcare Ltd's latest financial results for the quarter ending December 2025 reflect a significant operational performance, characterized by robust growth in both revenue and net profit. The company reported a year-on-year revenue increase of 62.00%, reaching ₹70.34 crores, which notably surpasses its five-year sales growth rate of 16.59%. This acceleration indicates effective market penetration and possibly favorable industry dynamics. The net profit for the same period surged by 126.27% year-on-year to ₹10.25 crores, showcasing strong profitability driven by improved operational efficiency and cost management. The operating margin, excluding other income, improved to 26.43%, marking a substantial enhancement from the previous quarter. This margin expansion is attributed to better operating leverage as revenue scaled, alongside controlled employee costs and reduced interest expenses. Despite thes...

Read full news article

View All News